Insider · CIK 0001277631
BASKETT FOREST
Reports to the SEC for 95 companies · MENLO PARK, CA
Transactions
50
Companies
95
Filings
4
CIK
0001277631
Forms 4 and 5
Insider transactions
| Date | Company | Value |
|---|---|---|
| 2026-03-10 | KRROKorro Bio, Inc.P Purchase | +$2.3M |
| 2026-03-10 | KRROKorro Bio, Inc. · Pre-Funded WarrantsP Purchase | +$2.7M |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series A Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.P Purchase | +$15M |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series D Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series C-2 Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series C-1 Preferred StockC Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc.C Conversion | — |
| 2026-02-09 | SGPSpyGlass Pharma, Inc. · Series B Preferred StockC Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$1,863 |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$4,340.25 |
| 2025-10-02 | NEUENeueHealth, Inc.F Tax Payment | −$3,719.25 |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)A Award | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Series A Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$1,861.28 |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$4,342.97 |
| 2025-10-02 | NEUENeueHealth, Inc. · Series B Convertible Perpetual Preferred StockD Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.S Sale | −$1,890 |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)X Exercise of In-Money | — |
| 2025-10-02 | NEUENeueHealth, Inc.M Exercise/Conversion | +$3,722.55 |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc.X Exercise of In-Money | +$1,891.95 |
| 2025-10-02 | NEUENeueHealth, Inc.D Disposition to Issuer | — |
| 2025-10-02 | NEUENeueHealth, Inc. · Warrant (Right to Buy)M Exercise/Conversion | — |
| 2025-04-17 | TRVITrevi Therapeutics, Inc. · 3.5-Year Common Stock WarrantX Exercise of In-Money | — |
| 2025-04-17 | TRVITrevi Therapeutics, Inc.X Exercise of In-Money | +$2.54M |
| 2024-10-01 | NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase | — |
| 2024-10-01 | NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase | — |
| 2024-10-01 | NEUENeueHealth, Inc. · Warrant (Right to Buy)P Purchase | — |
| 2024-09-16 | MBXMBX Biosciences, Inc. · Series B Convertible Preferred StockC Conversion | — |
| 2024-09-16 | MBXMBX Biosciences, Inc. · Series A Convertible Preferred StockC Conversion | — |
| 2024-09-16 | MBXMBX Biosciences, Inc.P Purchase | +$8M |
Recent filings
- 4BASKETT FOREST0001193125-26-104716SEC(opens sec.gov)
- 5BASKETT FOREST0001193125-26-051528SEC(opens sec.gov)
- 4BASKETT FOREST0001193125-26-046673SEC(opens sec.gov)
- 4BASKETT FOREST0001193125-25-232134SEC(opens sec.gov)
Companies
- Achaogen, Inc.10% Owner
- Adaptimmune Therapeutics PLC10% OwnerADAP
- AEROHIVE NETWORKS, INC10% Owner
- Akouos, Inc.10% Owner
- AMICUS THERAPEUTICS, INC.10% Owner
- Annexon, Inc.10% OwnerANNX
- APPIAN CORP10% OwnerAPPN
- Arcellx, Inc.10% Owner
- ARDELYX, INC.10% OwnerARDX
- ARYx Therapeutics, Inc.10% Owner
- ATHEROS COMMUNICATIONS INCDirector
- AUDIENCE INCDirector
- Avalo Therapeutics, Inc.10% OwnerAVTX
- AVEO PHARMACEUTICALS, INC.10% Owner
- Berkshire Grey, Inc.10% Owner
- Black Diamond Therapeutics, Inc.10% OwnerBDTX
- BOX INC10% OwnerBOX
- BuzzFeed, Inc.10% OwnerBZFD
- Care.com Inc10% Owner
- Cascadian Therapeutics, Inc.10% Owner
- Casper Sleep Inc.10% Owner
- CHAMPIONS ONCOLOGY, INC.10% OwnerCSBR
- CHANNELADVISOR CORP10% Owner
- Cloudflare, Inc.10% OwnerNET
- Clovis Oncology, Inc.10% Owner
- Coursera, Inc.10% OwnerCOUR
- CRESCENT BIOPHARMA, INC.10% OwnerCBIO
- CVENT INC10% Owner
- Dermira, Inc.10% Owner
- Desktop Metal, Inc.10% Owner
- Eargo, Inc.10% Owner
- Echo Global Logistics, Inc.10% Owner
- Elastic N.V.10% OwnerESTC
- Enliven Therapeutics, Inc.10% OwnerELVN
- Epizyme, Inc.10% Owner
- FUSION-IO, INC.Director
- Galera Therapeutics, Inc.10% OwnerGRTX
- GENOCEA BIOSCIENCES, INC.10% Owner
- Groupon, Inc.10% OwnerGRPN
- HYPERION THERAPEUTICS INC10% Owner
- INNERWORKINGS INC10% Owner
- Inozyme Pharma, Inc.10% Owner
- INTERLEUKIN GENETICS INC10% Owner
- IonQ, Inc.10% OwnerIONQ
- KINETA, INC./DE10% Owner
- Korro Bio, Inc.10% OwnerKRRO
- Liquidia Technologies Inc10% Owner
- Loxo Oncology, Inc.10% Owner
- Marker Therapeutics, Inc.10% OwnerMRKR
- MBX Biosciences, Inc.10% OwnerMBX
- Mersana Therapeutics, Inc.10% OwnerMRSN
- Metacrine, Inc.10% Owner
- Millennial Media Inc.10% Owner
- MINERVA SURGICAL INC10% OwnerUTRS
- Mirum Pharmaceuticals, Inc.10% OwnerMIRM
- Monte Rosa Therapeutics, Inc.10% OwnerGLUE
- MULESOFT, INC10% Owner
- NeueHealth, Inc.Director, 10% OwnerNEUE
- Nightstar Therapeutics plc10% Owner
- Nkarta, Inc.10% OwnerNKTX
- Omthera Pharmaceuticals, Inc.Director, 10% Owner, Director by Deputization
- OnKure Therapeutics, Inc.10% OwnerOKUR
- OPOWER, INC.10% Owner
- Oruka Therapeutics, Inc.10% OwnerORKA
- Oyster Point Pharma, Inc.10% Owner
- PEPLIN INC10% Owner
- PhaseBio Pharmaceuticals Inc10% Owner
- Ra Pharmaceuticals, Inc.10% Owner
- Regulus Therapeutics Inc.Former 10% Owner
- RHYTHM PHARMACEUTICALS, INC.10% OwnerRYTM
- Robinhood Markets, Inc.DirectorHOOD
- Sagimet Biosciences Inc.10% OwnerSGMT
- Savara Inc10% OwnerSVRA
- Senti Biosciences Holdings, Inc.10% OwnerSNTI
- Sorrento Tech, Inc.10% Owner
- Sprout Social, Inc.10% OwnerSPT
- SpyGlass Pharma, Inc.10% OwnerSGP
- SUPERNUS PHARMACEUTICALS, INC.10% OwnerSUPN
- Surface Oncology, Inc.10% Owner
- SYNLOGIC, INC.10% OwnerSYBX
- Tableau Software IncDirector
- Tempest Therapeutics, Inc.10% OwnerTPST
- TESARO, Inc.10% Owner
- Tintri, Inc.10% Owner
- Tracon Pharmaceuticals, Inc.10% Owner
- TREVENA INC10% Owner
- Trevi Therapeutics, Inc.10% OwnerTRVI
- TriVascular Technologies, Inc.10% Owner
- Verona Pharma plc10% OwnerVRNA
- Viracta Therapeutics, Inc.10% OwnerVIRX
- Workday, Inc.10% OwnerWDAY
- X4 Pharmaceuticals, Inc10% OwnerXFOR
- XOOM Corp10% Owner
- ZeroFox Holdings, Inc.10% Owner
- Zosano Pharma Corp10% Owner
Address
2855 SAND HILL ROAD
MENLO PARK, CA, 94025